Investors / United States / Osage University Partners
Osage University Partners
Venture capital · Bala Cynwyd, PA, United States · North America
Osage University Partners is a venture capital firm that invests in startups commercializing deep technology and science-driven research emerging from universities and research institutions. It provides capital and support to these companies, including follow-on funding, and works with a network of over 150 university and research institution partners.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsdeep techuniversity spinoutslife sciencessoftwareclimate techmedtech
Your fit with Osage University Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOsage University Partners lists 58 checked portfolio companies on its own site and is named in 10 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (37%), AI & Machine Learning (19%) and Industrial & Manufacturing (12%). 92% of its companies are based in United States. It invests most often alongside RA Capital, ARCH Venture Partners and 8VC.
Counts come from funding rounds that name Osage University Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Osage University Partners' whole history. Rounds on record name 10 companies; its own site lists 58. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 10% |
| Seed | 0% |
| Series A | 50% |
| Series B | 20% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 4 | 0 |
| '26 | 6 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 87th | 58 companies |
| Recent activity | 91th | 7 rounds in 12 months |
| Early stage | 55th | 10% of entries at pre-seed or seed |
| Evidence | 78th | 10% of companies confirmed by a round |
| Sector focus | 68th | 37% in its largest sector |
| Reach | 69th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 37% | 15% |
| AI & Machine Learning | 19% | 18% |
| Industrial & Manufacturing | 12% | 7% |
| Cybersecurity | 10% | 4% |
| Robotics & Hardware | 5% | 1% |
| Enterprise Software | 5% | 8% |
| Consumer | 4% | 3% |
| Mobility & Logistics | 3% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 7 |
| ARCH Venture Partners | 4 |
| 8VC | 3 |
| A&E Investments | 3 |
| Agent Capital | 3 |
| Avoro Capital Advisors | 3 |
| Canaan | 3 |
| Cisco Investments | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5290%
- No longer answers00%
- Points to another company610%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Osage University Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Osage University Partners| Date | Company | Stage |
|---|---|---|
| 29 Sept 2026 | Pre-Seed Led | |
| 24 Aug 2026 | Series A | |
| 6 May 2026 | Series A | |
| 15 Apr 2026 | Series C+ | |
| 12 Jan 2026 | Series B | |
| 7 Jan 2026 | Series B | |
| 17 Dec 2025 | Series A | |
| 4 Aug 2025 | Series A |
Round details for Osage University Partners
Amounts, full round histories and every co-investor in Osage University Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
58 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Addition Therapeutics is advancing a pipeline of therapeutics to deliver functional cures for patients with severe lifelong diseases | Healthcare & Biotech | Dec 2025Series A | Funding round | |
| Ambiq makes unprecedented energy-efficient SoCs and ultra-low power platform solutions that enable edge AI on billions of battery-powered devices. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| Antiva Biosciences is developing a novel topical therapeutic for the treatment of oncogenic human papillomavirus infections and pre-cancerous cervical lesions | Healthcare & Biotech | Portfolio page | ||
| Arsenal Biosciences, Inc. is a cell therapy company that discovers and develops next-generation in vivo T cell therapies to address chronic disease, including cancer and autoimmunity. | Healthcare & Biotech | Portfolio page | ||
| AssetWatch provides an end-to-end condition monitoring service for industrial plants using AI-driven predictive maintenance and expert partnership | Industrial & Manufacturing | Apr 2025Series C+ | Funding round | |
| The company is harnessing the biology of human aging to develop new therapies for cardiometabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Brimstone produces cement, steel, aluminum, and critical minerals from a single rock using a breakthrough process. | Industrial & ManufacturingMobility & Logistics | Aug 2025Series A | Page + round | |
| Cartesia provides realtime AI models and voice agents for various industries, including financial services, healthcare, and retail. | AI & Machine LearningEnterprise Software | Portfolio page | ||
| Censys provides internet intelligence and insights for security operations and exposure management. | Cybersecurity | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Context Therapeutics develops next-generation T cell engaging bispecific antibody therapies for the treatment of solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Corelight transforms network data into definitive evidence | CybersecurityAI & Machine Learning | Portfolio page | ||
| The company is a clinical stage biopharmaceutical company. | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
Industrial & ManufacturingAI & Machine Learning | Portfolio page | |||
| EnaChip enables next-generation switches for AI data centers with its power delivery technology | AI & Machine LearningSpace & Defense | Portfolio page | ||
| Eridu AI develops networking technology for artificial intelligence applications | AI & Machine LearningCybersecurity | Portfolio page | ||
| Everactive creates self-powered chips for wireless Ambient IoT devices that can sense, process, and wirelessly transmit data continuously using energy harvested from the environment. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Portfolio page | ||||
| Glyphic Biotechnologies is developing a high-throughput proteome sequencing technology | Healthcare & Biotech | Portfolio page |
About this data
site last read 10 Nov 2026- Site
- oup.vc
- Last read
- 10 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 12 Mar 2025
- Companies checked
- 58
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Osage University Partners' profile as data
Pull Osage University Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/oup.vc
# also
GET /v1/firms/oup.vc/portfolio
GET /v1/firms/oup.vc/coinvestors
GET /v1/firms/oup.vc/news